Imugene
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAImugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group's lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.
Contact Details
37 Bligh Street, Suite 1006, Level 10, SYDNEY NSW 2000
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 786th |  | Imugene | $10.5m |
| 893rd | | Exopharm | $3.4m |
| 915th | | Amaero International | $2.8m |
| 916th | | ioneer | $2.8m |
| 920th | | Optiscan Imaging | $2.6m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 106th | Amaero International | 90% | |
| 741st | Optiscan Imaging | -0% | 13% |
| 855th | Imugene | -8% | 41% |
| 1052nd | Exopharm | -22% | -52% |
| 1680th | ioneer | -66% | -5% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEWS: Tagged in Cancer-fighting mission shoots Imugene up ASX boards | 13 Nov 2023 |
| NEW ROLE: Giovanni Selvaggi, | 30 Oct 2023 |
| NEW ROLE: Jakob Dupoint, | 30 Oct 2023 |
| NEWS: Tagged in Healthtech banks on rising numbers | 07 Nov 2022 |
| NEW ROLE: Monil Shah, | 23 Sep 2022 |
| NEWS: Tagged in Where markets meet medicine; a biotech entrepreneur at the tip of the spear | 14 Feb 2022 |
| NEWS: Tagged in Radiopharm scores coup with rare isotope supply deal | 01 Feb 2022 |
| NEW ROLE: Rita Laeufle, | 15 Oct 2021 |
| NEW ROLE: Mark Marino, Chief Medical Officer | 24 Nov 2020 |
